USA Financial Formulas bought a new stake in shares of Exelon Co. (NASDAQ:EXC - Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 32,821 shares of the company's stock, valued at approximately $1,512,000. Exelon makes up approximately 0.2% of USA Financial Formulas' holdings, making the stock its 24th biggest position.
A number of other large investors also recently modified their holdings of EXC. Ameriflex Group Inc. purchased a new position in shares of Exelon during the 4th quarter valued at $25,000. Millstone Evans Group LLC purchased a new stake in Exelon in the 4th quarter worth $28,000. Capital Advisors Ltd. LLC lifted its stake in Exelon by 119.6% in the 4th quarter. Capital Advisors Ltd. LLC now owns 942 shares of the company's stock worth $35,000 after purchasing an additional 513 shares in the last quarter. SBI Securities Co. Ltd. purchased a new stake in Exelon in the 4th quarter worth $36,000. Finally, Stonebridge Financial Group LLC purchased a new stake in Exelon in the 4th quarter worth $40,000. Hedge funds and other institutional investors own 80.92% of the company's stock.
Exelon Trading Up 1.8%
Exelon stock traded up $0.76 during midday trading on Thursday, reaching $43.64. The stock had a trading volume of 7,719,701 shares, compared to its average volume of 7,368,200. The company has a quick ratio of 0.78, a current ratio of 0.87 and a debt-to-equity ratio of 1.61. Exelon Co. has a 52-week low of $34.01 and a 52-week high of $48.11. The firm has a market cap of $44.06 billion, a price-to-earnings ratio of 17.81, a price-to-earnings-growth ratio of 2.86 and a beta of 0.39. The company has a fifty day moving average of $44.81 and a 200 day moving average of $42.17.
Exelon (NASDAQ:EXC - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The company reported $0.92 earnings per share for the quarter, topping analysts' consensus estimates of $0.86 by $0.06. The company had revenue of $6.71 billion for the quarter, compared to analyst estimates of $6.30 billion. Exelon had a net margin of 10.68% and a return on equity of 9.52%. The firm's revenue for the quarter was up 11.1% on a year-over-year basis. During the same period in the prior year, the company posted $0.68 EPS. On average, analysts anticipate that Exelon Co. will post 2.64 earnings per share for the current fiscal year.
Exelon Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, June 13th. Shareholders of record on Monday, May 12th will be paid a $0.40 dividend. The ex-dividend date is Monday, May 12th. This represents a $1.60 dividend on an annualized basis and a yield of 3.67%. Exelon's dividend payout ratio is currently 59.48%.
Wall Street Analysts Forecast Growth
EXC has been the topic of several research analyst reports. Guggenheim boosted their price target on shares of Exelon from $47.00 to $50.00 and gave the stock a "buy" rating in a research note on Friday, May 2nd. BMO Capital Markets upped their target price on shares of Exelon from $46.00 to $50.00 and gave the company an "outperform" rating in a research report on Monday, April 28th. Scotiabank upped their target price on shares of Exelon from $42.00 to $44.00 and gave the company a "sector perform" rating in a research report on Thursday, February 13th. Morgan Stanley decreased their target price on shares of Exelon from $49.00 to $48.00 and set an "equal weight" rating on the stock in a research report on Thursday, May 22nd. Finally, KeyCorp cut shares of Exelon from a "sector weight" rating to an "underweight" rating and set a $39.00 target price on the stock. in a research report on Wednesday, May 14th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and four have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus target price of $47.40.
Read Our Latest Research Report on Exelon
About Exelon
(
Free Report)
Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.
Further Reading
Before you consider Exelon, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exelon wasn't on the list.
While Exelon currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
